These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 8584278)
1. Regional biotransformation of MPTP in the CNS of rodents and its relation to neurotoxicity. Nwanze E; Souverbie F; Jonsson G; Sundström E Neurotoxicology; 1995; 16(3):469-77. PubMed ID: 8584278 [TBL] [Abstract][Full Text] [Related]
2. Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: Systemic administration. Giovanni A; Sieber BA; Heikkila RE; Sonsalla PK J Pharmacol Exp Ther; 1994 Sep; 270(3):1000-7. PubMed ID: 7932147 [TBL] [Abstract][Full Text] [Related]
4. In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity. Zuddas A; Fascetti F; Corsini GU; Piccardi MP Exp Neurol; 1994 May; 127(1):54-61. PubMed ID: 8200437 [TBL] [Abstract][Full Text] [Related]
5. A model of chronic neurotoxicity: long-term retention of the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) within catecholaminergic neurons. Johannessen JN Neurotoxicology; 1991; 12(2):285-302. PubMed ID: 1956587 [TBL] [Abstract][Full Text] [Related]
6. Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 2: Central administration of 1-methyl-4-phenylpyridinium. Giovanni A; Sonsalla PK; Heikkila RE J Pharmacol Exp Ther; 1994 Sep; 270(3):1008-14. PubMed ID: 7932148 [TBL] [Abstract][Full Text] [Related]
7. MK-801 temporarily prevents MPTP-induced acute dopamine depletion and MPP+ elimination in the mouse striatum. Chan P; Langston JW; Di Monte DA J Pharmacol Exp Ther; 1993 Dec; 267(3):1515-20. PubMed ID: 8263813 [TBL] [Abstract][Full Text] [Related]
9. Effect of MPTP and its pyridinium metabolites on monoamine uptake and on central catecholamine neurons in mice. Jonsson G; Nwanze E; Luthman J; Sundström E Acta Physiol Scand; 1986 Oct; 128(2):187-94. PubMed ID: 3535380 [TBL] [Abstract][Full Text] [Related]
10. Effects of the parkinsonism-inducing neurotoxin MPTP and its metabolite MPP+ on sympathetic adrenergic nerves in mouse iris and atrium. Luthman J; Jonsson G Med Biol; 1986; 64(2-3):95-102. PubMed ID: 3489145 [TBL] [Abstract][Full Text] [Related]
11. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. II. Susceptibility among mammalian species correlates with the toxin's metabolic patterns in brain microvessels and liver. Riachi NJ; Harik SI; Kalaria RN; Sayre LM J Pharmacol Exp Ther; 1988 Feb; 244(2):443-8. PubMed ID: 3258032 [TBL] [Abstract][Full Text] [Related]
13. Production and disposition of 1-methyl-4-phenylpyridinium in primary cultures of mouse astrocytes. Di Monte DA; Wu EY; Irwin I; Delanney LE; Langston JW Glia; 1992; 5(1):48-55. PubMed ID: 1311704 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata. Staal RG; Sonsalla PK J Pharmacol Exp Ther; 2000 May; 293(2):336-42. PubMed ID: 10773000 [TBL] [Abstract][Full Text] [Related]
15. Catecholamine transporters and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: studies comparing the cloned human noradrenaline and human dopamine transporter. Pifl C; Hornykiewicz O; Giros B; Caron MG J Pharmacol Exp Ther; 1996 Jun; 277(3):1437-43. PubMed ID: 8667208 [TBL] [Abstract][Full Text] [Related]
16. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo. Saporito MS; Brown EM; Miller MS; Carswell S J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541 [TBL] [Abstract][Full Text] [Related]
17. Neurotoxicity studies with the monoamine oxidase B substrate 1-methyl-3-phenyl-3-pyrroline. Ogunrombi MO; Malan SF; Terre'Blanche G; Castagnoli K; Castagnoli N; Bergh JJ; Petzer JP Life Sci; 2007 Jul; 81(6):458-67. PubMed ID: 17655878 [TBL] [Abstract][Full Text] [Related]
18. Sensitive and selective liquid chromatography/tandem mass spectrometry methods for quantitative analysis of 1-methyl-4-phenyl pyridinium (MPP+) in mouse striatal tissue. Zhang MY; Kagan N; Sung ML; Zaleska MM; Monaghan M J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Oct; 874(1-2):51-6. PubMed ID: 18824419 [TBL] [Abstract][Full Text] [Related]
19. Effect of dopaminergic neurotoxin MPTP/MPP+ on coenzyme Q content. Dhanasekaran M; Karuppagounder SS; Uthayathas S; Wold LE; Parameshwaran K; Jayachandra Babu R; Suppiramaniam V; Brown-Borg H Life Sci; 2008 Jul; 83(3-4):92-5. PubMed ID: 18565546 [TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease. Schmidt N; Ferger B Synapse; 2001 Apr; 40(1):47-54. PubMed ID: 11170221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]